Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Diabetic Retinopathy
100%
Type 2 Diabetes Mellitus (T2DM)
76%
Type 2 Diabetic Patients
49%
Diabetes
30%
Retina
28%
Non-diabetic
27%
Type 1 Diabetes Mellitus (T1DM)
27%
Retinal pigment Epithelium
25%
Retinal Degeneration
24%
Insulin Resistance
21%
Sex Hormone-binding Globulin
20%
Topical Administration
20%
Db Mouse
19%
Obesity
19%
Diabetic Patients
18%
Type I Diabetes
18%
Cardiovascular Risk
17%
Fenofibrate
17%
Adipose Tissue
16%
Experimental Diabetes
16%
Vitreous Fluid
15%
Neurodegeneration
15%
Beneficial Effects
15%
Diabetic Macular Edema
14%
Mild Cognitive Impairment
14%
Bariatric Surgery
14%
Somatostatin
13%
Diabetic
13%
Alzheimer's Disease
13%
Overexpression
13%
Fenofibric Acid
13%
Cognitive Impairment
12%
Molecular Mechanism
12%
Hemoglobin A1c (HbA1c)
11%
Erythropoietin
11%
Eye Drops
11%
Proliferative Diabetic Retinopathy
11%
Early Events
10%
MRNA Level
10%
Clinical Practice
10%
Blood-retinal Barrier
10%
Arterial Stiffness
10%
Diabetic Eye
9%
Vascular Leakage
9%
Retinal Microperimetry
9%
Liver
9%
Diabetic Retina
9%
Diabetes Complications
9%
Sitagliptin
9%
Advanced Glycation End Products
9%
Medicine and Dentistry
Diabetic Retinopathy
68%
Maturity Onset Diabetes of the Young
50%
Diabetes Mellitus
49%
Diabetes
39%
Patient with Type 2 Diabetes
20%
Neurodegeneration
18%
Insulin Resistance
18%
Diseases
18%
Case-Control Study
17%
Biological Marker
16%
Cardiovascular Risk
14%
Insulin Dependent Diabetes Mellitus
13%
Sex Hormone Binding Globulin
13%
Alzheimer's Disease
12%
Bariatric Surgery
12%
Retinal Pigment Epithelium
12%
Cognitive Defect
12%
Prevalence
11%
Vasculotropin
11%
Arterial Stiffness
11%
Cardiovascular Disease
11%
Neuroprotective Agent
10%
Hemoglobin A1c
9%
Fenofibrate
9%
Vitreous
9%
Advanced Glycation End-Product
9%
Messenger RNA
8%
Mild Cognitive Impairment
8%
Impaired Glucose Tolerance
8%
Cardiovascular System
8%
Breathing
7%
Lung
7%
Diabetic Macular Edema
7%
Body Mass Index
7%
Glycemic Control
7%
Proliferative Diabetic Retinopathy
6%
Fenofibric Acid
6%
Chronic Hepatitis C
6%
Epithelial Cell
6%
Pulse Wave Velocity
6%
Blood Glucose
6%
Microangiopathy
6%
Hyperglycemia
6%
Cognitive Decline
6%
Patient with Type 1 Diabetes
5%
Complications of Diabetes Mellitus
5%
Tight Junction
5%
Lung Function
5%
Neuroprotection
5%
Receptor
5%